>
Nemaura Medical Inc logo

NMRD - Nemaura Medical Inc Share Price

$5.92 0.1  1.5%

Last Trade - 18/10/21

Sector
Healthcare
Size
Small Cap
Market Cap £100.5m
Enterprise Value £96.1m
Revenue £n/a
Position in Universe 5229th / 7245
Bullish
Bearish
Unlock NMRD Revenue
Momentum
Relative Strength (%)
1m -16.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -66.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 1.00 3.00
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 30 June 2021, NemauraMedical Inc revenues was not reported. Net loss increasedfrom $1.1M to $3.3M. Higher net loss reflects Interestexpense increase from $189K to $1.7M (expense), General andadministrative increase from $596K to $1.3M (expense).Basic Earnings per Share excluding Extraordinary Itemsdecreased from -$0.05 to -$0.14.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for NMRD
Graphical History

Revenue

NMRD Revenue Unlock NMRD Revenue

Net Income

NMRD Net Income Unlock NMRD Revenue

Normalised EPS

NMRD Normalised EPS Unlock NMRD Revenue

PE Ratio Range

NMRD PE Ratio Range Unlock NMRD Revenue

Dividend Yield Range

NMRD Dividend Yield Range Unlock NMRD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NMRD EPS Forecasts Unlock NMRD Revenue
Profile Summary

Nemaura Medical Inc. is a medical technology company. The Company is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The Company's subsidiaries include Region Green Limited.

Directors
Last Annual March 31st, 2021
Last Interim June 30th, 2021
Incorporated December 24, 2013
Public Since November 4, 2014
No. of Shareholders: 84
No. of Employees: 25
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 23,308,039
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NMRD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NMRD
Upcoming Events for NMRD
Frequently Asked Questions for Nemaura Medical Inc
What is the Nemaura Medical Inc share price?

As of 18/10/21, shares in Nemaura Medical Inc are trading at $5.92, giving the company a market capitalisation of £100.5m. This share price information is delayed by 15 minutes.

How has the Nemaura Medical Inc share price performed this year?

Shares in Nemaura Medical Inc are currently trading at $5.92 and the price has moved by 47.63% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nemaura Medical Inc price has moved by 13.15% over the past year.

What are the analyst and broker recommendations for Nemaura Medical Inc?

There are no analysts currently covering Nemaura Medical Inc.

When will Nemaura Medical Inc next release its financial results?

Nemaura Medical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Nemaura Medical Inc dividend yield?

Nemaura Medical Inc does not currently pay a dividend.

Does Nemaura Medical Inc pay a dividend?

Nemaura Medical Inc does not currently pay a dividend.

When does Nemaura Medical Inc next pay dividends?

Nemaura Medical Inc does not currently pay a dividend.

How do I buy Nemaura Medical Inc shares?

To buy shares in Nemaura Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nemaura Medical Inc?

Shares in Nemaura Medical Inc are currently trading at $5.92, giving the company a market capitalisation of £100.5m.

Where are Nemaura Medical Inc shares listed? Where are Nemaura Medical Inc shares listed?

Here are the trading details for Nemaura Medical Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: NMRD
What kind of share is Nemaura Medical Inc?

Based on an overall assessment of its quality, value and momentum, Nemaura Medical Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Nemaura Medical Inc share price forecast 2021?

Shares in Nemaura Medical Inc are currently priced at $5.92. At that level they are trading at 0.204% discount to the analyst consensus target price of 0.00.

Analysts covering Nemaura Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.47 for the next financial year.

How can I tell whether the Nemaura Medical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nemaura Medical Inc. Over the past six months, the relative strength of its shares against the market has been 5.89%. At the current price of $5.92, shares in Nemaura Medical Inc are trading at -22.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nemaura Medical Inc PE Ratio?

We were not able to find PE ratio data for Nemaura Medical Inc.

Who are the key directors of Nemaura Medical Inc?

Nemaura Medical Inc's management team is headed by:

Dewan Chowdhury - CHM
Bashir Timol - DRC
Timothy Johnson - IND
Salim Natha - IND
Thomas Moore - IND
Justin Mclarney - CFO
Who are the major shareholders of Nemaura Medical Inc?

Here are the top five shareholders of Nemaura Medical Inc based on the size of their shareholding:

Chowdhury (Dewan Fazlul Hoque) Individual Investor
Percentage owned: 37.56% (8.75m shares)
Timol (Bashir) Individual Investor
Percentage owned: 11.62% (2.71m shares)
Ismail (Sufyan) Individual Investor
Percentage owned: 9.74% (2.27m shares)
Natha (Salim) Individual Investor
Percentage owned: 1.72% (401k shares)
Russell Investments Trust Company Investment Advisor
Percentage owned: 1.16% (271k shares)
Similar to NMRD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.